Uncategorized

The EAN strongly endorses the newly published EBC perspective paper on Rethinking Alzheimer's Disease given that Alzheimer's disease is a devastating neurological disease affecting more and more people in Europe and across the world due to ageing societies.

Regular EAN Masterclass participant Elena Bondareva gives her account of the format, calling it "an excellent platform for neurologists to deepen their expertise in a collaborative and engaging atmosphere".

This Manifesto outlines the current situation in relation to dementia across Europe and makes specific demands for the European Union (EU), as well as for national governments.

Individual registration for the EAN 2021 Congress is now back online, with a 10% discount available until May 10!

COVID-19 around the World: Clinician interviews on experience and impact of the virus (Saudi Arabia)

Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform

COVID-19 around the World: Clinician interviews on experience and impact of the virus (New Zealand)

This year’s Annual Pain Forum was organised online due to the COVID-19 pandemic.

Fellowship Reports 2019

Fellow: Nicolas Jean Dubuisson, Belgium Term of the Fellowship: March – September 2019 Hosting department: Department of Neurology and Neurosurgery, Neuromuscular Disorders, University Medical Center (UMC) Utrecht, The Netherlands Supervisor: Dr. H.S. Goedee, PhD These 6 weeks in Utrecht were… Continue Reading

Neurology Prof. Gert-Jan Lammers became a chair of Sleep disorders at the Leiden University Medical Centre

EAN Scientific Panel Neuro-oncology invites you to take part in their survey:

This review, recently published in JAMA Neurology, serves to summarise available information regarding coronaviruses in the nervous system, identifies potential tissue targets and routes of entry of SARS-CoV-2 into the central nervous system, describes the range of clinical neurological complications that have been reported thus far in COVID-19, and their potential pathogenesis.

Symposium 6 shed light on the autonomic disorders in a broad range of neurological and paraphysiological conditions through either pre-clinical and clinical studies as well as novel treatment approaches.

As any place in Europe and beyond, the French health system is still under pressure and Covid-19 has already and will profoundly change healthcare.